Egil Lingaas

665 total citations
29 papers, 475 citations indexed

About

Egil Lingaas is a scholar working on Epidemiology, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Egil Lingaas has authored 29 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 7 papers in Infectious Diseases and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Egil Lingaas's work include Infection Control in Healthcare (5 papers), Infection Control and Ventilation (5 papers) and Antibiotic Resistance in Bacteria (4 papers). Egil Lingaas is often cited by papers focused on Infection Control in Healthcare (5 papers), Infection Control and Ventilation (5 papers) and Antibiotic Resistance in Bacteria (4 papers). Egil Lingaas collaborates with scholars based in Norway, United Kingdom and Croatia. Egil Lingaas's co-authors include Karl-Erik Giercksky, Frode Samdal, P. F. Amland, Tore Midtvedt, Frank Åbyholm, Dag Torfoss, Erik H. Strøm, Ingvild Nordøy, Ingar Olsen and Kristin O’Sullivan and has published in prestigious journals such as Water Research, JNCI Journal of the National Cancer Institute and Biochemical and Biophysical Research Communications.

In The Last Decade

Egil Lingaas

24 papers receiving 444 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Egil Lingaas Norway 11 158 89 63 58 57 29 475
Ali Mojtahedi Iran 16 87 0.6× 91 1.0× 43 0.7× 218 3.8× 60 1.1× 71 627
Coburn H. Allen United States 10 204 1.3× 85 1.0× 35 0.6× 28 0.5× 11 0.2× 25 677
Magda Diab‐Elschahawi Austria 15 126 0.8× 197 2.2× 27 0.4× 93 1.6× 12 0.2× 33 581
E T Houang United Kingdom 13 70 0.4× 154 1.7× 36 0.6× 129 2.2× 18 0.3× 21 522
Mohammad Taghi Akhi Iran 16 135 0.9× 136 1.5× 26 0.4× 271 4.7× 63 1.1× 46 626
Rosa Cremades Spain 10 91 0.6× 86 1.0× 62 1.0× 53 0.9× 22 0.4× 28 367
Bengt Hellmark Sweden 16 185 1.2× 310 3.5× 26 0.4× 82 1.4× 53 0.9× 33 705
Anette Stájer Hungary 12 68 0.4× 95 1.1× 35 0.6× 125 2.2× 42 0.7× 22 580
Doaa Ghaith Egypt 14 77 0.5× 81 0.9× 48 0.8× 263 4.5× 39 0.7× 46 546
Alfizah Hanafiah Malaysia 18 376 2.4× 89 1.0× 29 0.5× 83 1.4× 21 0.4× 58 782

Countries citing papers authored by Egil Lingaas

Since Specialization
Citations

This map shows the geographic impact of Egil Lingaas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Egil Lingaas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Egil Lingaas more than expected).

Fields of papers citing papers by Egil Lingaas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Egil Lingaas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Egil Lingaas. The network helps show where Egil Lingaas may publish in the future.

Co-authorship network of co-authors of Egil Lingaas

This figure shows the co-authorship network connecting the top 25 collaborators of Egil Lingaas. A scholar is included among the top collaborators of Egil Lingaas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Egil Lingaas. Egil Lingaas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Andersson, Rune, Egil Lingaas, Ingemar Qvarfordt, & Ann Tammelin. (2025). Prevention of viral transmission must be assured before re-use of infusion sets. European Journal of Anaesthesiology. 42(3). 278–279.
3.
Tronstad, Christian, et al.. (2021). Quantification of aerosol dispersal from suspected aerosol-generating procedures. ERJ Open Research. 7(4). 206–2021. 6 indexed citations
4.
Kühn, Inger, Roland Möllby, Kristin O’Sullivan, et al.. (2019). Diversity and antibiotic resistance among Escherichia coli populations in hospital and community wastewater compared to wastewater at the receiving urban treatment plant. Water Research. 161. 232–241. 66 indexed citations
5.
Lingaas, Egil, et al.. (2017). Varicella-zoster-virus – behov for bedre smittevern. Tidsskrift for Den norske legeforening. 137(19). 1 indexed citations
6.
Lingaas, Egil, et al.. (2016). Polyheksanid – sikkerhet og effekt som antiseptikum. Tidsskrift for Den norske legeforening. 136(8). 707–711. 33 indexed citations
7.
Roques, Christine, Adriano Dusé, Rose Gallagher, et al.. (2015). Consensus Statement: Patient Safety, Healthcare-Associated Infections and Hospital Environmental Surfaces. Future Microbiology. 10(10). 1629–1634. 3 indexed citations
8.
Johansen, Jeanette E., Tone Westergren, & Egil Lingaas. (2011). Profylaktisk behandling etter varicellaeksponering. Tidsskrift for Den norske legeforening. 131(17). 1645–1648. 5 indexed citations
9.
Lingaas, Egil, et al.. (2010). A large outbreak of Listeria monocytogenes infection with short incubation period in a tertiary care hospital. Journal of Infection. 61(6). 465–470. 57 indexed citations
10.
Olsen, Ingar, Finnur Snorrason, & Egil Lingaas. (2010). Should patients with hip joint prosthesis receive antibiotic prophylaxis before dental treatment?. Journal of Oral Microbiology. 2(1). 5265–5265. 12 indexed citations
11.
Lingaas, Egil, et al.. (2010). Factors interfering with the microflora on hands: a regression analysis of samples from 465 healthcare workers. Journal of Advanced Nursing. 67(2). 297–307. 36 indexed citations
12.
Lingaas, Egil, et al.. (2009). Impact of Finger Rings on Transmission of Bacteria During Hand Contact. Infection Control and Hospital Epidemiology. 30(5). 427–432. 20 indexed citations
13.
Lingaas, Egil, et al.. (2007). Impact of a Single Plain Finger Ring on the Bacterial Load on the Hands of Healthcare Workers. Infection Control and Hospital Epidemiology. 28(10). 1191–1195. 19 indexed citations
14.
Lingaas, Egil, et al.. (1996). Generation of hydroxyl radicals by polymorphonuclear neutrophils during exposure to direct current and iron. Apmis. 104(7-8). 493–499. 4 indexed citations
15.
Amland, P. F., et al.. (1995). A Prospective, Double-Blind, Placebo-Controlled Trial of a Single Dose of Azithromycin on Postoperative Wound Infections in Plastic Surgery. Plastic & Reconstructive Surgery. 96(6). 1378–1383. 85 indexed citations
16.
Lundblad, Runar, Meng Yu Wang, Gunnar Kvalheim, Egil Lingaas, & Karl‐Erik Giercksky. (1995). GRANULOCYTE COLONY-STIMULATING FACTOR IMPROVES MYELOPOIESIS AND HOST DEFENSE IN FULMINANT INTRA-ABDOMINAL SEPSIS IN RATS. Shock. 4(1). 68–73. 27 indexed citations
17.
Kjeldsen‐Kragh, Jens, et al.. (1995). Inhibition of growth of Proteus mirabilis and Escherichia coli in urine in response to fasting and vegetarian diet. Apmis. 103(7-8). 818–822. 2 indexed citations
18.
Lingaas, Egil & Tore Midtvedt. (1989). The influence of cefoperazone, cefotaxime, ceftaridime and aztreonam on phagocytosis by human neutrophils in vitro. Journal of Antimicrobial Chemotherapy. 23(5). 701–710. 6 indexed citations
19.
Steinbakk, Martin, et al.. (1987). IN VITRO ACTIVITY OF CEFTAZIDIME, CEFOTAXIME AND GENTAMICIN AGAINST 11,521 CLINICAL ISOLATES OF BACTERIA. Acta Pathologica Microbiologica Scandinavica Series B Microbiology. 95B(1-6). 337–346. 1 indexed citations
20.
Olsen, Ingar, et al.. (1984). Scanning and transmission electron microscopy of the phagocytosis of Treponema denticola and Escherichia coli by human neutrophils in vitro. European Journal Of Oral Sciences. 92(4). 282–293. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026